Showing results (791-800 of 1,516) with videos related to

Sort By:
Pageof 152
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2017
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studiesN Boeckx, R Koukakis, K Op de Beeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.
The Oncologist|October 27, 2007
Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomasMaría Dolores Tabernero, Ana Belén Espinosa, Angel Maillo, et al.
Structure (London, England : 1993)|November 15, 2016
Structural Basis for Selective Interaction between the ESCRT Regulator HD-PTP and UBAP1Deepankar Gahloth, Colin Levy, Graham Heaven, et al.
Human Pathology|February 1, 1997
Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detectionM Garcia-Isidoro, M D Tabernero, J L Garcia, et al.
ESMO Open|November 16, 2016
Quality of life during first-line FOLFOX4±panitumumab in <i>RAS</i> wild-type metastatic colorectal carcinoma: results from a randomised controlled trialSalvatore Siena, Josep Tabernero, Gyorgy Bodoky, et al.
Revista Clinica Espanola|April 7, 2005
[Macroscopic liver pathology in patients with dissociated cholestasis]J L Polo Sabau, M D García Lorenzo, M Molina Robles, et al.
Actas Urologicas Espanolas|August 4, 2006
[Analysis of a laparoscopic radical prostatectomy program with 544 cases]J R Cansino Alcaide, M Alvarez Maestro, P M Castillo Cabrera, et al.
Therapeutic Advances in Medical Oncology|August 13, 2020
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancerGiulia Martini, Rodrigo Dienstmann, Javier Ros, et al.
Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR <i>BRAF</i>V600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.
Pageof 152